November 8, 2014
Notes: Blumenberg, Miroslav
Research Support, Non-U.S. Gov’t
Expert Rev Mol Diagn. 2013 Nov;13(8):885-94. doi: 10.1586/14737159.2013.846827.
Author Address: The R.O. Perelman Department of Dermatology, Department of Biochemistry and Molecular Pharmacology, the NYU Cancer Institute, NYU Langone Medical Center, NYU School of Medicine, 455 First Avenue, P.H.B. Room 874, New York NY 10016, USA.
Reference Type: Journal Article
Record Number: 4363Author: Boehncke, W. H. and Kirby, B.
Title: GRAPPA Fellows Symposium adjacent to the European Academy of Dermatology and Venerology meeting, Verona, 2012: a meeting report
Journal: J Rheumatol
Short Title: GRAPPA Fellows Symposium adjacent to the European Academy of Dermatology and Venerology meeting, Verona, 2012: a meeting report
Alternate Journal: The Journal of rheumatology
ISSN: 0315-162X (Print)
Accession Number: 23908534
Keywords: Antibodies, Monoclonal, Humanized/therapeutic use
Immunoglobulin G/therapeutic use
Receptors, Tumor Necrosis Factor/therapeutic use
Vitamin D/therapeutic use
Abstract: The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) organized a Fellows Symposium adjacent to the European Academy of Dermatology and Venerology (EADV) spring meeting in Verona, Italy, in 2012. Wolf-Henning Boehncke from Geneva and Brian Kirby from Dublin formed the faculty. Five papers were presented, followed by extended discussions among participants and faculty. Two contributions were on comorbidities of psoriasis patients and 2 on treatment of non-plaque-type psoriasis; the fifth presentation was a discussion of possible modes of action of vitamin D derivatives in the treatment of psoriasis. Summaries of all 5 papers are included here.